Rezvoglar (insulin glargine-aglr) is a long-acting type of insulin used to treat type 1 and type 2 diabetes. Rezvoglar is a biosimilar for lantus (insulin glargine). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Rezvoglar may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Get Rezvoglar for as low as $280.63, which is 16% off the average retail price of $332.16 for the most common version, by using a GoodRx coupon. Learn about saving on prescription medications with GoodRx Companion.